Search Results

Filter
  • 1-10 of  355 results for ""Porphobilinogen""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rapid spectrophotometric quantification of urinary porphyrins and porphobilinogen as screening tool for attacks of acute porphyria.

  • Authors : Lang A; University Hospital, Laser-Forschungslabor, LIFE-Center, LMU Munich, Munich, Germany.; University Hospital, Department of Urology, LMU Munich, Munich, Germany.

Subjects: Porphobilinogen/Porphobilinogen/Porphobilinogen/*urine ; Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/*diagnosis ; Porphyrins/Porphyrins/Porphyrins/*urine

  • Source: Journal of biomedical optics [J Biomed Opt] 2018 May; Vol. 23 (5), pp. 1-12.Publisher: Published by SPIE--the International Society for Optical Engineering in cooperation with International Biomedical Optics Society Country of Publication: United

Record details

×
Academic Journal

Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.

  • Authors : Ruspini SF; Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Argentina.; Zuccoli JR

Subjects: Models, Genetic*; Anesthetics/Anesthetics/Anesthetics/*pharmacology ; Heme/Heme/Heme/*metabolism

  • Source: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2018 Jun; Vol. 1862 (6), pp. 1296-1305. Date of Electronic Publication: 2018 Feb 22.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0304-4165

Record details

×
Academic Journal

Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria.

Subjects: Acetylgalactosamine/Acetylgalactosamine/Acetylgalactosamine/*analogs & derivatives ; Aminolevulinic Acid/Aminolevulinic Acid/Aminolevulinic Acid/*urine ; Porphobilinogen/Porphobilinogen/Porphobilinogen/*urine

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Jul; Vol. 108 (1), pp. 63-72. Date of Electronic Publication: 2020 Mar 07.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

×
Academic Journal

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.

Subjects: RNAi Therapeutics*; Acetylgalactosamine/Acetylgalactosamine/Acetylgalactosamine/*analogs & derivatives ; Aminolevulinic Acid/Aminolevulinic Acid/Aminolevulinic Acid/*urine

  • Source: The New England journal of medicine [N Engl J Med] 2020 Jun 11; Vol. 382 (24), pp. 2289-2301.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Acute intermittent porphyria and anti-tuberculosis therapy.

  • Authors : Golla R; From the Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.; Mukherjee A

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*adverse effects ; Brain/Brain/Brain/*pathology ; Glucose/Glucose/Glucose/*administration & dosage

  • Source: QJM : monthly journal of the Association of Physicians [QJM] 2020 Mar 01; Vol. 113 (3), pp. 207-208.Publisher: Published for the Association of Physicians of Great Britain and Ireland by the Oxford University Press Country of Publication: England NLM ID: 9438285

Record details

×
Academic Journal

Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl-3-acryloylglycine in urine of patients with acute intermittent porphyria.

  • Authors : Marcos J; Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader 88, Barcelona, 08003, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, Barcelona, 08003, Spain.

Subjects: Biomarkers/Biomarkers/Biomarkers/*urine ; Glycine/Glycine/Glycine/*analogs & derivatives ; Mass Spectrometry/Mass Spectrometry/Mass Spectrometry/*methods

  • Source: Journal of mass spectrometry : JMS [J Mass Spectrom] 2015 Jul; Vol. 50 (7), pp. 929-37.Publisher: Wiley Country of Publication: England NLM ID: 9504818 Publication Model: Print Cited Medium: Internet ISSN: 1096-9888 (Electronic)

Record details

×
Academic Journal

Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.

  • Authors : Sardh E; Department of Internal Medicine, Karolinska Institute, Stockholm Söder Hospital, Stockholm, Sweden. ; Rejkjaer L

Subjects: Aminolevulinic Acid*/Aminolevulinic Acid*/Aminolevulinic Acid*/blood ; Aminolevulinic Acid*/Aminolevulinic Acid*/Aminolevulinic Acid*/urine ; Heterozygote*

  • Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2007; Vol. 46 (4), pp. 335-49.Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Print ISSN: 0312-5963 (Print) Linking

Record details

×
Academic Journal

Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.

  • Authors : Marsden JT; Department of Clinical Biochemistry, King's College Hospital, , London, UK.; Rees DC

Subjects: Aminolevulinic Acid/Aminolevulinic Acid/Aminolevulinic Acid/*urine ; Porphobilinogen/Porphobilinogen/Porphobilinogen/*urine ; Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/*urine

  • Source: Journal of clinical pathology [J Clin Pathol] 2014 Jan; Vol. 67 (1), pp. 60-5. Date of Electronic Publication: 2013 Aug 01.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.

  • Authors : Zhang J; Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, Fifth Avenue at 100th Street, New York, NY 10029, USA.; Yasuda M

Subjects: Aminolevulinic Acid/Aminolevulinic Acid/Aminolevulinic Acid/*blood ; Aminolevulinic Acid/Aminolevulinic Acid/Aminolevulinic Acid/*urine ; Chromatography, Liquid/Chromatography, Liquid/Chromatography, Liquid/*methods

  • Source: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2011 Aug 15; Vol. 879 (24), pp. 2389-96. Date Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.

  • Authors : Sardh E; Department of Internal Medicine, Karolinska Institutet, Stockholm Söder Hospital, Sweden. ; Harper P

Subjects: Drug Monitoring/Drug Monitoring/Drug Monitoring/*methods ; Porphobilinogen/Porphobilinogen/Porphobilinogen/*blood ; Porphobilinogen/Porphobilinogen/Porphobilinogen/*urine

  • Source: European journal of internal medicine [Eur J Intern Med] 2009 Mar; Vol. 20 (2), pp. 201-7. Date of Electronic Publication: 2008 Aug 08.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  355 results for ""Porphobilinogen""